OncoPrecision
Signal active
Organization
Contact Information
Overview
Leveraging single cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
About
Industries
Biotechnology, Therapeutics, Oncology
Founded
2020
Employees
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
OncoPrecision headquartered in New York, New York, United States, North America, operates in the Biotechnology, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $149.8M in funding across 36 round(s). With a team of 11-50 employees, OncoPrecision is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - OncoPrecision, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$4.2M
Details
2
OncoPrecision has raised a total of $4.2M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 850.0K | ||
| 2022 | Seed | 3.3M |
Investors
OncoPrecision is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| SOSV | - | FUNDING ROUND - SOSV | undefined |
| IndieBio | - | FUNDING ROUND - IndieBio | undefined |
| OncoPrecision | - | FUNDING ROUND - OncoPrecision | undefined |
| Air Capital | - | FUNDING ROUND - Air Capital | undefined |
Recent Activity
There is no recent news or activity for this profile.